Patents
Patents for C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
10/2011
10/12/2011EP2373634A1 Morpholinone compounds as factor ixa inhibitors
10/05/2011EP2370411A2 Compounds having antiparasitic or anti-infectious activity
09/2011
09/29/2011US20110237776 Aromatic compounds with sulfur containing ligands
09/29/2011US20110237511 EP4 Receptor Agonist, Compositions and Methods Thereof
09/29/2011US20110236982 Analysis of mass spectral data in the quiet zones
09/29/2011US20110236395 Treatment of fibrotic eye disorders using an mmp2 inhibitor
09/28/2011CN102203213A Novel organic electroluminescent compounds and organic electroluminescent device using the same
09/28/2011CN102203076A Novel organic electroluminescent compounds and organic electroluminescent device using the same
09/27/2011US8026231 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof
09/22/2011WO2011115150A1 Method for producing benzothiazine compound
09/22/2011WO2011114137A1 Toluidine blue derivatives as photosensitising compounds
09/21/2011CN101283019B Polymer and light-emitting polymer element using the same
09/20/2011US8022208 Benzene derivative or salt thereof
09/20/2011US8022204 Process of making 3-phenylimino-3H-phenothiazine
09/20/2011US8022018 Quaternized dithiazines and method of using same in treatment of wells
09/20/2011US8022017 Method of using dithiazine to inhibit corrosion
09/14/2011CN101291676B Amidines derivative and use of medicine
09/08/2011US20110218192 Inhibitors Of Beta-Secretase
09/07/2011CN102177153A Compositions and methods for treating alcohol use disorders, pain and other diseases
09/06/2011US8012962 Substituted thiomorpholine derivatives
09/01/2011WO2011105700A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
09/01/2011US20110212173 Controlled Release Treatment of Depression
08/2011
08/31/2011EP1984345B1 Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents
08/30/2011US8008480 Process for the purification of meloxicam
08/25/2011US20110207739 Novel 1, 2-Disubstituted Amido-anthraquinone Derivatives, Preparation Method and application thereof
08/24/2011CN101665472B Preparation method of 2-methyl-3. 4-dihydro-4-oxo-2H-1. 2-benzothiazine-3-carboxylic ethyl ester-1, 1-dioxide
08/17/2011EP2356109A2 Compositions and methods for treating alcohol use disorders, pain and other diseases
08/17/2011CN102159556A 1,4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment of neurodegenerative conditions
08/17/2011CN101273049B A method of manufacturing an organic silicon compound that contains a methacryloxy group or an acryloxy group
08/16/2011CA2636985C Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents
08/11/2011US20110196147 Inhibitors of histone deacetylase
08/04/2011WO2011093603A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
08/04/2011WO2011093444A1 Acrylic rubber composition and rubber crosslinked product
08/04/2011WO2011093443A1 Fused heterocyclic compound and composition
08/04/2011WO2011036558A9 Crystalline methylthioninium chloride hydrates
08/04/2011CA2787784A1 Small molecules for the modulation of mcl-1 and methods of modulating cell death, cell division, cell differentiation and methods of treating disorders
07/2011
07/27/2011CN101094835B Novel dicarboxamide derivatives
07/21/2011US20110178071 Antiviral Treatments
07/21/2011US20110177007 Dithienopyrrole Dyes for Imaging and Therapy
07/21/2011US20110177006 Dithienofuran Dyes for Imaging and Therapy
07/19/2011USRE42562 EP4 receptor agonist, compositions and methods thereof
07/14/2011US20110172195 Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance
07/12/2011US7977476 Methods of attaching biological compounds to solid supports using triazine
07/06/2011CN102115466A Sultam compounds, preparation method thereof and midbody
07/05/2011CA2446136C Pyruvate derivatives
06/2011
06/30/2011WO2011077726A1 4-amino-1,3-thiazine or oxazine derivative
06/30/2011US20110158989 Poly (ADP-Ribose) Polymerase (PARP) INHIBITORS
06/29/2011EP2338059A1 Ligands for aggregated tau molecules
06/28/2011US7968707 Reacting an amino, hydroxy substituted amide with a heterocyclic substituted carboxylic acid to produce (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl) amino-3-hydroxy-5-[2S-1-imidazolidin-2-onyl)-3-methyl-butanoyl] amino-1,6-diphenylhexane; inhibitors of HIV infection
06/23/2011US20110152246 Novel inhibitors of hepatitis c virus replication
06/23/2011US20110150873 Anti-inflammatory compositions and combinations
06/21/2011CA2641379C Heterobicyclic sulfonamide derivatives for the treatment of diabetes
06/16/2011WO2011071109A1 Fused heterocyclic compound having amino group
06/16/2011WO2011071057A1 Pharmaceutical composition for treatment or prevention of alzheimer's disease containing sulfur-containing heterocyclic derivative
06/16/2011WO2011070781A1 Substituted aminothiazine derivative
06/14/2011US7960376 Benzo-fused heterocycles
06/09/2011WO2011067306A1 Cyclohexane derivatives as inhibitors of acetyl-coa carboxylase (acc)
06/09/2011US20110136792 Novel carboxylic acid analogs as glycogen synthase activators
06/09/2011US20110136735 Cyclohexane derivatives and uses thereof
06/09/2011US20110135650 Morpholinone compounds as factor ixa inhibitors
06/08/2011EP2328877A2 1,4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment of neurodegenerative conditions
06/07/2011US7956193 Intramolecular C-H amination with sulfonyl azides
06/07/2011US7956183 Methods of synthesis and/or purification of diaminophenothiazinium compounds
05/2011
05/31/2011CA2493390C A process for production of high-purity enamines
05/26/2011US20110124856 Aminopropylidene derivative
05/25/2011EP2325169A2 Lisofylline analogues and their pharmeacuetical uses
05/25/2011CN1578663B Inhibitors of histone deacetylase
05/25/2011CN102070565A 4-alkyl-6-aryl-5-acetyl-1, 3-thiazine, and preparation method and application thereof
05/24/2011US7947688 N-[3-(3-substituted-pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-sulfonamides, and compositions, and methods related thereto
05/19/2011WO2011057892A1 2,3-dihydrobenzoxazine and 2,3-dihydrobenzothiazine derivates as hif-inhibitors for the treatment of cancer and inflammatory diseases
05/19/2011WO2011036561A3 Process
05/19/2011US20110118244 Factor xa inhibitors
05/19/2011US20110118199 Use of cns penetrating anticancer compounds for the treatment of protozoal diseases
05/18/2011EP2322517A1 Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (MTC)
05/17/2011US7943320 Unsymmetrical cyanine dyes for high resolution nucleic acid melting analysis
05/12/2011US20110112076 Selective hydroxamic acid based mmp-12 and mmp-13 inhibitors
05/12/2011US20110111959 Pollen tube stimulants from arabidopsis pistils
05/11/2011CN101602747B Preparation and application of 3, 7-disubstituted-N-hexyl phenothiazine derivative
05/10/2011US7939537 HIV integrase inhibitors
05/10/2011US7939525 Conjugated psychotropic drugs and uses thereof
05/05/2011WO2011051692A1 Therapeutic peptides
05/05/2011US20110105748 Novel beta-phenyl-alpha-oxysubstituted propionic derivatives: process for its preparation and their use in the preparation of pharmaceutically important compounds
05/05/2011US20110105486 Thiazole derivatives
05/05/2011US20110105481 Filamin a binding anti-inflammatory and analgesic
05/05/2011CA2777749A1 Therapeutic peptides
05/03/2011US7935685 Process for preparation of inclusion compounds between a non-steroidal anti-inflammatory drug and betacyclodextrin by microwave treatment
05/03/2011CA2484340C 2-(quinolonyl)-fused heterocycles as androgen receptor modulators
04/2011
04/28/2011WO2011047432A1 Fused ring analogues of anti-fibrotic agents
04/27/2011CN102030721A Method for synthesizing chiral benzosultam via palladium-catalytic asymmetric hydrogenation
04/26/2011CA2447999C Caspase inhibitors and uses thereof
04/21/2011WO2011047391A1 Fluorescent calcium indicators that are ratiometric and emit in the red spectrum
04/20/2011EP2311831A1 Fused bicyclic-substituted amines as histamine-3 receptor ligands
04/20/2011CN102024907A Photoelectric conversion device, production method thereof, photosensor, imaging device and their drive methods
04/13/2011CN102015667A Aminodihydrothiazine derivatives as BACE inhibitors for the treatment of alzheimer's disease
04/06/2011CN1946680B 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors
03/2011
03/31/2011WO2011036561A2 Process
03/31/2011WO2011036558A2 Crystalline methylthionium chloride (methylene blue) hydrates
03/31/2011CA2773306A1 Process
03/31/2011CA2773305A1 Crystalline methylthioninium chloride hydrates
03/30/2011EP1601643B1 Arylcycloalkyl derivatives with branched side chains as ppar receptor modulators, method for their production and their use as medicaments
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 ... 52